Biocept Stock News

The shares of Biocept Inc (NASDAQ: BIOC) increased by over 20% pre-market. This is why it happened.

SAN DIEGO--(BUSINESS WIRE)--Study shows Biocept's CNSide assay detects and analyzes tumor cells in lung cancer patients, improving treatment decisions that may extend life.

Biocept Inc (NASDAQ:BIOC) reported positive net income for the first half of 2021 as revenues rose due to the increased use of the firm's COVID-19 RT-PCR  tests, notably in the first quarter. In the

Biocept, Inc. (BIOC) CEO Michael Nall on Q2 2021 Results - Earnings Call Transcript

Biocept Inc. said it has appointed David Karlander as senior vice president of Commercial Operations.

SAN DIEGO--(BUSINESS WIRE)--Biocept Names David Karlander Senior Vice President of Commercial Operations.

Biocept Inc (NASDAQ: BIOC) received a favorable final Local Coverage Determination expanding Medicare coverage for the use of its Target Selector assay to identify the HER2 biomarker from circulat

Biocept Inc (NASDAQ:BIOC) (FRA:B003) said it has received a positive final Local Coverage Determination (LCD) from the Centers for Medicare & Medicaid Services (CMS) Molecular Diagnostics Program (Mo

SAN DIEGO--(BUSINESS WIRE)-- #breastcancer--Biocept receives Medicare coverage for breast cancer assay to detect and analyze HER2 biomarker and announces CNSide and COVID-19 testing updates.

Biocept Inc (NASDAQ:BIOC) (FRA:B003) has expanded its board of directors to nine members from seven and named director since 2020 Samuel D Riccitelli as the company's new chairman as the diagnostics

SAN DIEGO--(BUSINESS WIRE)--Biocept appointed Linda Rubinstein and Antonino Morales to its Board of Directors, and named Director Samuel D. Riccitelli as Chairman of the Board.

Biocept Inc (NASDAQ:BIOC) (FRA:B003) announced that it was added to the Russell Microcap Index as the US market opened on June 28, 2021.  The Russell Microcap Index is a broadly used performance benc

SAN DIEGO--(BUSINESS WIRE)---- $BIOC #Russell_Microcap_Index--Biocept joins the Russell Microcap Index

Biocept Inc (NASDAQ:BIOC) (FRA:B003) has announced a collaboration with Quest Diagnostics Inc (NYSE:DGX) (FRA:QDI) to provide laboratory testing services to Quest patients for its Target Selector NGS

12:15pm: The Dow was down 161 points, 0.5%, at 34,233 at midday. The Nasdaq lost 85 points, 0.6%, to 14,088, and the S&P 500 ticked down 11 points, 0.3%, to 4,244.